CRD.B vs. EHTH, MMC, AON, AJG, BRO, SLQT, WDH, TWFG, GOCO, and RDZN
Should you be buying Crawford & Company stock or one of its competitors? The main competitors of Crawford & Company include eHealth (EHTH), Marsh & McLennan Companies (MMC), AON (AON), Arthur J. Gallagher & Co. (AJG), Brown & Brown (BRO), SelectQuote (SLQT), Waterdrop (WDH), TWFG (TWFG), GoHealth (GOCO), and Roadzen (RDZN). These companies are all part of the "insurance agents, brokers, & service" industry.
Crawford & Company vs.
eHealth (NASDAQ:EHTH) and Crawford & Company (NYSE:CRD.B) are both small-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, earnings, risk, valuation, profitability, media sentiment, institutional ownership and dividends.
eHealth has a beta of 0.32, suggesting that its share price is 68% less volatile than the S&P 500. Comparatively, Crawford & Company has a beta of 0.74, suggesting that its share price is 26% less volatile than the S&P 500.
79.5% of eHealth shares are owned by institutional investors. Comparatively, 11.0% of Crawford & Company shares are owned by institutional investors. 4.1% of eHealth shares are owned by insiders. Comparatively, 51.0% of Crawford & Company shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
In the previous week, eHealth had 1 more articles in the media than Crawford & Company. MarketBeat recorded 1 mentions for eHealth and 0 mentions for Crawford & Company. eHealth's average media sentiment score of 0.00 equaled Crawford & Company'saverage media sentiment score.
eHealth received 315 more outperform votes than Crawford & Company when rated by MarketBeat users. Likewise, 61.76% of users gave eHealth an outperform vote while only 54.02% of users gave Crawford & Company an outperform vote.
Crawford & Company has a net margin of 1.55% compared to eHealth's net margin of -7.58%. Crawford & Company's return on equity of 22.34% beat eHealth's return on equity.
eHealth currently has a consensus price target of $6.38, suggesting a potential downside of 36.57%. Given eHealth's stronger consensus rating and higher probable upside, equities analysts plainly believe eHealth is more favorable than Crawford & Company.
Crawford & Company has higher revenue and earnings than eHealth. eHealth is trading at a lower price-to-earnings ratio than Crawford & Company, indicating that it is currently the more affordable of the two stocks.
Summary
Crawford & Company beats eHealth on 9 of the 17 factors compared between the two stocks.
Get Crawford & Company News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRD.B and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CRD.B vs. The Competition
Crawford & Company Competitors List
Related Companies and Tools
This page (NYSE:CRD.B) was last updated on 2/22/2025 by MarketBeat.com Staff
Free CRD.B Stock Alerts